Literature DB >> 23709556

Rupture of splenic angiosarcoma: a rare cause of spontaneous haemoperitoneum.

Henrique Alexandrino1, Maria José Julião, José Guilherme Tralhão, Francisco Castro Sousa.   

Abstract

Primary splenic angiosarcoma, a very rare mesenchymal tumour of endothelial cell origin, comprises 2.6% of all cases of angiosarcoma and 10% of all primitive splenic tumours. Clinical presentation is usually unspecific, with abdominal pain and anaemia. Rupture is a rare complication and should prompt emergency splenectomy. Prognosis is usually poor because of liver, lung or bone metastases. We describe the case of an 80-year-old woman admitted to the emergency room with syncope, hypotension and vomiting. She stabilised after fluid resuscitation. Investigations showed anaemia, a large, heterogeneous spleen and free fluid in the abdominal cavity. She underwent emergency splenectomy. Pathology revealed primary splenic angiosarcoma. The postoperative period was complicated by respiratory failure but the patient made an otherwise uneventful course and was discharged 2 weeks after surgery. Six months after the operation she remains free of disease with no adjuvant treatment.

Entities:  

Mesh:

Year:  2013        PMID: 23709556      PMCID: PMC3669906          DOI: 10.1136/bcr-2013-009748

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  15 in total

1.  Primary angiosarcoma of the spleen.

Authors:  Jun-Te Hsu; Han-Ming Chen; Chin-Yew Lin; Chun-Nan Yeh; Tsann-Long Hwang; Yi-Yin Jan; Miin-Fu Chen
Journal:  J Surg Oncol       Date:  2005-12-15       Impact factor: 3.454

2.  Occult rupture of the spleen.

Authors:  M J McMahon; J D Lintott; W S Mair; P W Lee; J S Duthie
Journal:  Br J Surg       Date:  1977-09       Impact factor: 6.939

3.  [A case of primary splenic angiosarcoma with intraperitoneal hemorrhage treated by transcatheter arterial embolization].

Authors:  Toru Takamatsu; Kouichi Toukai; Masatoshi Ikeda; Shinya Ushimaru; Takeharu Asano; Norihiro Matsumoto; Takaaki Iwaki; Masanori Fukunishi; Noriyoshi Sagihara; Hiroyuki Miyatani; Yukio Yoshida; Shigeki Yamada
Journal:  Nihon Shokakibyo Gakkai Zasshi       Date:  2011-04

4.  Splenic angiosarcoma: a clinicopathologic and immunophenotypic study of 28 cases.

Authors:  T S Neuhauser; G A Derringer; L D Thompson; J C Fanburg-Smith; M Miettinen; A Saaristo; S L Abbondanzo
Journal:  Mod Pathol       Date:  2000-09       Impact factor: 7.842

5.  Splenic tumour: a clinicopathological study.

Authors:  L W Chen; R N Chien; C L Yen; L C Chang
Journal:  Int J Clin Pract       Date:  2004-10       Impact factor: 2.503

6.  Angiosarcoma of the spleen: imaging characteristics in 12 patients.

Authors:  William M Thompson; Angela D Levy; Nadine S Aguilera; Luis Gorospe; Robert M Abbott
Journal:  Radiology       Date:  2005-03-04       Impact factor: 11.105

Review 7.  Primary and secondary neoplasms of the spleen.

Authors:  R K Kaza; S Azar; M M Al-Hawary; I R Francis
Journal:  Cancer Imaging       Date:  2010-08-13       Impact factor: 3.909

8.  Primary angiosarcoma of the spleen. A clinicopathologic study of 40 cases.

Authors:  S Falk; J Krishnan; J M Meis
Journal:  Am J Surg Pathol       Date:  1993-10       Impact factor: 6.394

9.  Primary splenic angiosarcoma.

Authors:  Kamran S Hamid; Joaquin A Rodriguez; Terry C Lairmore
Journal:  JSLS       Date:  2010 Jul-Sep       Impact factor: 2.172

10.  Systemic therapy in primary angiosarcoma of the spleen.

Authors:  Bruna Pellini Ferreira; Eve T Rodler; Elizabeth T Loggers; Seth M Pollack; Robin L Jones
Journal:  Rare Tumors       Date:  2012-11-13
View more
  2 in total

1.  Spontaneous rupture of primary splenic angiosarcoma: A case report.

Authors:  Botao Xu; Xiaona Xie; Xiong Zhou; Menghe Zhai; Wenjun Yang
Journal:  Oncol Lett       Date:  2015-09-16       Impact factor: 2.967

2.  Treatment with sorafenib plus camrelizumab after splenectomy for primary splenic angiosarcoma with liver metastasis: A case report and literature review.

Authors:  Dan Pan; Tai-Ping Li; Jian-Hui Xiong; Shu-Bo Wang; Yao-Xu Chen; Jian-Feng Li; Qi Xiao
Journal:  World J Clin Cases       Date:  2022-03-26       Impact factor: 1.337

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.